Senior insider sale
Chief Port. Strat & Alnce Ofcr at SUTRO BIOPHARMA, INC. — senior position signals high conviction
$60.9K
12.19K shares
What this filing means
VASQUEZ NICKI plans to sell 12.19K shares of SUTRO BIOPHARMA, INC. valued at approximately $60.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/29/2024ACC: 0001950047-24-000502
Officer· Chief Port. Strat & Alnce Ofcr
Since Aug 2021
12.19K
Shares to sell
$60.9K
Approx. market value
12.19K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months5
Restricted Stock
Not Applicable
7/12/2022
2.13KRestricted Stock
Not Applicable
3/5/2022
3.25KRestricted Stock
Not Applicable
1/29/2022
1.48KRestricted Stock
Not Applicable
1/29/2021
1.47KRestricted Stock
Not Applicable
9/26/2020
3.87KTotal acquired12.19K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/12/2022 | Restricted Stock Not Applicable | 2.13K | — |
3/5/2022 | Restricted Stock Not Applicable | 3.25K | — |
1/29/2022 | Restricted Stock Not Applicable | 1.48K | — |
1/29/2021 | Restricted Stock Not Applicable | 1.47K | — |
9/26/2020 | Restricted Stock Not Applicable | 3.87K | — |
| Total | 12.19K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
12.19K
Market value
$60.9K
1/29/2024
Total
Units
12.19K
Value
$60.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
1/29/2024 | 12.19K | $60.9K | NASDAQ | Planned |
| Total | 12.19K | $60.9K | ||